(Q28168585)
Statements
Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes (English)
0 references
May 2004
0 references
125
0 references
5
0 references
1610-5
0 references